Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients

Philip D.H. Hamann, John D. Pauling, Neil Mchugh, Gavin Shaddick, Kimme Hyrich, Nicola Maiden, Tom Price, Neil Hopkinson, Sheila O'reilly, Lesley Hordon, Ian Griffiths, Duncan Porter, Hilary Capell, Andy Hassell, Romela Benitha, Ernest Choy, David Walsh, Paul Emery, Susan Knight, Ian BruceAllister Taggart, David Scott, Bev Harrison, Paul Thompson, Fiona Mccrae, Rhian Goodfellow, Marwan Bukhari, Peter Klimiuk, George Kitas, Ronald Jubb, Rikki Abernethy, Shane Clarke, Sandra Green, Paul Sanders, Amanda Coulson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2162-2169
Number of pages8
JournalRheumatology (United Kingdom)
Issue number12
Publication statusPublished - 1 Dec 2019
Externally publishedYes


  • biologic therapies
  • epidemiology
  • outcome measures
  • rheumatoid arthritis

Cite this